PDA Universe of Pre-Filled Syringes and Injection Devices Conference 2026

Abstract submissions must be received by 08 April 2026 for consideration.

Abstract Submission

Timeline

Submission Deadline
08 April 2026

Last day to submit abstracts, submission site closes at 23:59 EST

Each abstract must include the following information to be considered:

Abstract Title
(Max 25 words)
Abstract Overview
(Max 200 words)
Learning Objectives
(Max 100 words)

General Information

Abstract submitters may submit up to two entries for consideration.

All presentations must be free of commercial intent. Incomplete proposals will not be considered.

Share on LinkedIn Learn More About the Event Back to Open Calls for Abstracts

Call for Abstracts/Case Studies

The Program Planning Committee invites you to submit an abstract for a podium or poster presentation at the PDA Universe of Pre-Filled Syringes and Injection Devices Conference 2026. Case studies are particularly desired.

Jeffrey Givand, PhD

Merck

Christian Helbig

SCHOTT Pharma

Types of Submissions

Podium

20-minute oral presentations that are part of larger concurrent sessions, featuring 2-3 podium presentations. Content should be data-driven, objective, and free of commercial bias; case studies or real-world applications are strongly encouraged. One presenter per podium presentation; co-presenters are not permitted.

Poster

Visual presentations highlighting recent advancements, case studies, research findings, or innovative approaches in the industry. Posters should present data and outcomes clearly and without commercial bias. Printed posters are displayed in the Exhibit Hall during breaks and lunches with designated times for poster presenters to engage directly with attendees.

Lightning Presentation Great for first-time presenters!

Fast-paced, Pecha Kucha style-talks: 20 slides shown for 20 seconds each, advancing automatically (total time: 6 minutes, 40 seconds). Content should be focused, energetic, and memorable—ideal for sharing novel ideas, lessons learned, or key findings in a concise format.

Topics we are looking for:

Understanding the Interplay Between Drug Product and Device
- Container systems enabling new modalities and advanced formulations
- Formulation-container interactions
- Challenges in container component design and integration with devices
- Stability and aging impact on combination product performance
Computational Modeling, Machine Learning (ML), and Artificial Intelligence (AI)
- Leveraging AI, modeling, and simulation to streamline development
- Predicting combination product performance and reliability
- Process optimization using ML and modeling
- AI-enabled design controls and device risk management
- Regulatory considerations and opportunities for AI-enabled tools
Patient-Centered Design and Human Factors
- Novel strategies in human factors evaluation and usability testing
- Integrating patient needs, use environments, and use scenarios into design inputs
- Use-related risk identification and mitigation across the product lifecycle
- Needle design, performance, and usability considerations (including pain, safety, and training)
Process Development and Validation
- Advances in assembly, manufacturing, and automation
- Quality by Design (QbD) approaches for combination products
- Product design, development, and quality control strategies
- Validation strategies for complex delivery systems
Product and Delivery System Innovation
- Innovative product and delivery system designs
- Solutions to complex drug delivery challenges
- Delivery considerations for new modalities
- Advances in design verification method development and testing strategies
Sustainability and Materials Considerations
- Advances in sustainable materials and device design
- Circularity and lifecycle considerations for combination products
- Environmental impact reduction across manufacturing and delivery systems
Regulatory Strategies and Opportunities
- Case studies highlighting novel regulatory approaches for combination products
- Global regulatory strategy, including emerging market considerations
- EU MDR implementation challenges and impacts
- Notified Body engagement, expectations, and best practices

Poster Information

Poster presenters are responsible for printing and bringing their poster to the event.

To simplify the process, PDA will offer printing services through Shepard Expositions for an additional fee. Further details about this service will be provided if your poster is officially accepted.

Important

Poster presenters are required to pay a full conference registration fee.

Exhibition and Sponsorship Opportunities

PDA is seeking vendors who provide products/services in support of this conference. Space on-site is limited and is on a first-come, first-serve basis.

Exhibition: 06-07 October 2026

To reserve your space, please contact David Hall at [email protected].